Industry News

Join WhatsApp Channel

29 April 2020

Strides develops and commences export of Favipiravir Antiviral Tablets

Strides Pharma Science Limited (Strides or Company), a global pharmaceutical company today announced that it has developed and commercialized Favipiravir Antiviral tablets. The product is a generic version of Avigan® of Toyama Chemical, Japan. Favipiravir is an antiviral medication that was initially developed to treat influenza in Japan.
- Read more about Glenmark Pharmaceuticals receives ANDA tentative approval for Dapagliflozin and Saxagliptin Tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentativeapproval by the United States Food & Drug Administration (U.S. FDA) for Dapagliflozin and Saxagliptin Tablets, 10 mg/5 mg, the generic version of Qtern®1Tablets, 10 mg/5 mg, of AstraZeneca AB.
- Read more about Mylab collaborates with Shaw’s Syngene International
In a major step to make India self-reliant in COVID-19 testing, Mylab Discovery Solutions, a Pune based molecular diagnostics has collaborated with Kiran Mazumdar Shaw’s Syngene, a leading global contract research organization, to cater to India’s demand for RT-PCR COVID-19 testing kits.
- Read more about Indian Pharmaceutical Market shows growth of 8.9% in March despite COVID-19 crisis
Despite the COVID-19 crisis, the Indian Pharmaceutical market registered a surprising growth of 8.9% in Mar’20 with some evidence of panic buying in Chronic Medicines as reported by AIOCD AWACS.
- Read more about Cipla receives final approval for generic version of Proventil
Cipla Limited announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Albuterol Sulfate Inhalation Aerosol 90mcg (base)/actuation, from the United States Food and Drug Administration (US FDA).
- Read more about SMS Pharma provides updates against USFDA statement in connection with Ranitidine
In September 2019, The USFDA has observed that, some ranitidine medicines contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. SMS Pharma is one of the manufacturer of Ranitidine HCl Active Pharmaceuticals Ingredient (API).
- Read more about Lupin Contributes INR 21 crores Towards COVID-19 Relief Efforts
Pharma major Lupin Limited (Lupin) announced a contribution of INR 21 crores for relief efforts directed towards mitigating the COVID-19 crisis. Lupin’s Global Giving Program comprises of three separate contributions made by its employees, the Company and the promoter family.
- Read more about Pfizer joined with Biontech for covid19 vaccine development
BioNTech SE and Pfizer Inc disclosed additional details of their collaboration to advance candidates from BioNTech’s mRNA vaccine program, previously announced on March 17, 2020.
- Read more about FDA authorizes blood purification device to treat COVID-19
The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure.
- Read more about Sun Pharma reclaims market cap of Rs 1 trillion
Sun Pharmaceuticals shares are floating higher to Rs. 452.50 on BSE on Friday and expected to improve company's outlook. It was reached 52 week high at Rs. 479.90 on 10th April, 2020.